Association Between Financial Conflicts of Interests and Supportive Opinions for Erectile Dysfunction Treatment

Area of Science:

• Medical research methodology
• Pharmaceutical sciences
• Bioethics

Background:

• Conflict of interest (COI) arises when competing loyalties may compromise impartial judgment.
• Managing COI is crucial, especially in pharmaceutical research.
• Phosphodiesterase-5 Inhibitors (PDEIs) are widely used for erectile dysfunction.

Purpose of the Study:

• To investigate the association between declared financial conflicts of interest and the opinions expressed in publications on PDEI efficacy and safety.
• To evaluate the effectiveness of current COI management strategies.

Main Methods:

• A SCOPUS literature search identified publications on PDEI efficacy/safety.
• A categorization tool (CoOpCaT) classified publications based on support for the drug and COI reporting.
• Multivariable binary logistic regression analyzed the relationship between COI and supportive opinions.

Main Results:

• Out of 419 records, supportive opinions were more prevalent when a COI for the index drug was declared.
• The strongest predictor of a supportive opinion was the number of financial COIs declared for the index drug.
• A slight protective effect was observed with financial COIs declared for competitor drugs.

Conclusions:

• Financial COIs are frequently linked to bias in research.
• Current measures to mitigate COI bias appear to be ineffective.
• Further strategies for monitoring and compensating for COI bias are needed, but a definitive solution is not yet available.